References
- 1. KAl-Shoumer ASK, Al-Essa MT. Is there a relationship between vitamin D with insulin resistance and diabetes mellitus. World J Diabetes. 2015; 6(8): 1057-64.
- 2. Gedik O, Akahn S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia. 1986; 29(3): 142–5.
- 3. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008; 10(3): 185-97.
- 4. Naumovic N. Vitamin D-physiological importance. Med Pregl. 2010; 63 (5-6):301-4.
- 5. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010; 53(10): 2112-9.
- 6. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009; 48(6): 349-54.
- 7. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr. 2013; 5(1): 8.
- 8. Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, Olukoga AO, Boulton AJ. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J. 1994; 70(824): 440-3.
- 9. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007; 30(4): 980-6.
- 10. American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes—2015. Diabetes Care 2015; 38(Suppl. 1): S8–S16
- 11. Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016; 101(2): 394–415.
- 12. Wallace T, Levy J, Matthews D. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6): 1487-95.
- 13. Mattila C, Knekt P, Mannist OS, Rissanen H, Maarit A. Laaksonen M, et al. Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes. Diabetes care.2007; 30(10): 2569-70.
- 14. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et all. Vitamin D and calcium in-take in relation to type 2 diabetes in women. Diabetes Care. 2006; 29(3): 650-6.
- 15. Mcgill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008; 28; 7:4.
- 16. Drincic A, Armas L, Van Diest E, Heaney R. Volumetric Dilution, Rather Than Sequestration Best Explains the Low Vitamin D Status of Obesity. Obesity (Silver Spring). 2012; 20(7): 1444-8.
- 17. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et all. HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects. Diabetes Care. 2002; 25(7): 1135-41.
- 18. Yoon H, Jeon DJ, Park CE, You HS, Moon AE. Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults. J Clin Biochem Nutr. 2016; 59(2): 139-144.
- 19. Schuit FC. Factors determining the glucose sensitivity and glucose responsiveness of pancreatic beta cells. Horm Res. 1996; 46(3): 99-106.
- 20. Tengholm A. Cyclic AMP dynamics in the pancreatic b-cell. Ups J Med Sci. 2012; 117(4): 355-69.
- 21. Seino Y, Kurahachi H, Goto Y, Taminato T, Ikeda M, Imura H. Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease. Acta Diabetol Lat. 1975; 12(2): 89-99.
- 22. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. PNAS. 1987; 84(10): 3434–8.
- 23. Bourlon P-M, B Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999; 160(1): 87-95.
- 24. Berg JP, Haug E. Vitamin D: a hormonal regulator of the cAMP signaling pathway. Crit Rev Biochem Mol Biol. 1999; 34(5): 315-23.
- 25. Rudack-Garcia D, Henry H. Effect of Vitamin D Status on Cyclic AMP-dependent Protein Kinase Activity and Its Heat-stable Inhibitor in Chick Kidney. J biol chem. 1981; 256(21): 10781-5.
- 26. Vazquez G, Boland R, de Boland A. Modulation by 1,25(OH)2-vitamin D3 of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. BBA-mol cell res. 1995; 1269(1): 91–7.
- 27. Nilas L, Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes. 1984; 8(5): 407-11.
- 28. Boucher BJ, Mannan N, Noonan K, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995; 38(10): 1239-45.
- 29. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010; 103(4): 549-55.
- 30. Jeddi S, Syedmoradi L, Bagheripour F, Ghasemi A. The Effects of Vitamin D on Insulin Release From Isolated Islets of Rats. IntJEndocrinolMetab. 2015; 13(1): e20620.
- 31. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J ClinNutr. 2004; 79(5): 820-5.
- 32. Hedblad B, Nilsson P, Janzon L, Berglund G: Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med 2000;17:299-307